Innovative Pharmaceutical Biotech Limited announced that it expects to receive HKD 55.5 million in funding
On November 30, 2023, the company announced that it has entered into a further extension letter with the New CB Subscriber to extend the New CB Long Stop Date to January 31, 2024 or such other date as the Company and the New CB Subscriber may agree.